NIIMBL Project Call 10.1 (biopharmaceutical manufacturing technology & workforce)
NIIMBL Project Call 10.1 (biopharmaceutical manufacturing technology & workforce) is a funding call from NIIMBL (National Institute for Innovation in Manufacturing Biopharmaceuticals) that closes 07 January 2027. Funding: USD 8 million combined across projects (per-proposal maximum not stated). Eligibility: Submitters must be NIIMBL members; full proposals by invitation only (invites 19 Oct 2026); cost-share (non-federal) required.
- Funder
- NIIMBL (National Institute for Innovation in Manufacturing Biopharmaceuticals)
- Deadline
- 07 Jan 2027 (83 days)
- Status
- Open
- Amount
- USD 8 million combined across projects (per-proposal maximum not stated)
- Region / eligibility
- United States
- Career stage
- established / PI, industry / SME
- Fields
- crystallization, pharma process
- Reference
- —
- Official call
- Funder page (curated calendar) listing
Eligibility in plain language
Submitters must be NIIMBL members; full proposals by invitation only (invites 19 Oct 2026); cost-share (non-federal) required.
Who should apply
Crystal growth / crystallization researchers, medicinal chemists and pharma process / drug-development teams — best fit for PIs and research groups or companies and SMEs.
Summary from source
Member-driven RFP incl. Advanced Process Analytics, Product Quality & Real-Time Control, process intensification. Biopharma manufacturing projects incl. PAT/real-time control; concept stage closed 9 Sep 2026 – only invited teams submit full proposals by 7 Jan 2027. Watch for Project Call 11.